04/08/2026 | Press release | Distributed by Public on 04/08/2026 19:27
|
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | |||
|
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Series B Convertible Preferred Stock | 06/16/2025 | (1) | Common Stock | 200,000,000 | $0.5 | I | See footnote(2) |
| Common Stock Purchase Warrants | 06/16/2025 | 06/16/2027 | Common Stock | 220,000,000 | $0.5 | I | See footnote(2) |
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
SUN Weike C/O TRON INC. 941 W. MORSE BLVD WINTER PARK, FL 32789 |
X | X | ||
| /s/ Weike Sun | 04/08/2026 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | These securities do not have an expiration date. |
| (2) | The reported securities are held directly by Bravemorning Limited. Mr. Weike Sun is the sole shareholder of Bravemorning Limited and may be deemed to beneficially own the securities held by Bravemorning Limited. On June 16, 2025, Bravemorning Limited purchased 100,000 shares of Series B Convertible Preferred Stock, convertible into 200,000,000 shares of the Registrant's common stock at a conversion price of $0.50 per share and warrants to purchase up to 220,000,000 shares of the Registrant's common stock at an exercise price of $0.50 per share. |